Skip to content

Brady, Neal Statement on Bipartisan Commitment to Lower Drug Prices

February 12, 2019

Washington, D.C. – Today, the top Republican on the Ways and Means Committee Kevin Brady (R-TX) and Ways and Means Committee Chairman Richard Neal (D-MA) released the following statement ahead of a Full Committee Hearing on The Cost of Rising Prescription Drug Prices:

“We agree that the time is now to take meaningful action to lower the cost of prescription drugs in the U.S. health care system.  Consumers, taxpayers, employers, and our public programs like Medicare and Medicaid are all bearing the burden of years of high prices, unsustainable price increases, lack of transparency, and incentives in our government programs that too often reward high prices.   We are committed to working together to end this cycle while preserving access to life-saving innovations.”